Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial surface molecules represent a heterogeneous group of structural and functional entities that constitute the bacterial cell envelope and its appendages. This category includes peptidoglycan, lipopolysaccharides (LPS), teichoic acids, surface proteins such as adhesins and invasins, and capsular polysaccharides (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). These molecules are essential for maintaining osmotic stability, mediating interactions with the host environment, and facilitating nutrient uptake. From a therapeutic perspective, they are among the most successful drug targets; for instance, beta-lactam antibiotics inhibit the synthesis of the peptidoglycan layer, while polymyxins target the LPS of Gram-negative bacteria (Sarkar et al., 2021, Molecules). Additionally, surface molecules are primary targets for vaccine development, as they are often highly immunogenic and accessible to the host's immune system (Rappuoli et al., 2016, Nat Rev Immunol). However, the high degree of structural variability and the evolution of resistance mechanisms, such as target modification or capsule switching, present significant challenges for drug and vaccine efficacy. The rapid lysis of bacteria and subsequent release of these surface components can also trigger systemic inflammatory responses, such as the Jarisch-Herxheimer reaction (Dhaliwal et al., 2023, StatPearls). Understanding the molecular landscape of the bacterial surface is crucial for the design of next-generation precision antibiotics and conjugate vaccines.
Inhibition of cell wall biosynthesis, disruption of membrane integrity, or antibody-mediated neutralization of surface antigens.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial surface molecules.